首页> 外文期刊>Antimicrobial agents and chemotherapy. >Structure of the Enterovirus 71 3C Protease in Complex with NK-1.8k and Indications for the Development of Antienterovirus Protease Inhibitor
【24h】

Structure of the Enterovirus 71 3C Protease in Complex with NK-1.8k and Indications for the Development of Antienterovirus Protease Inhibitor

机译:肠道病毒71 3C蛋白酶的结构与NK-1.8K和抗扩手病毒蛋白酶抑制剂的发育的适应症

获取原文
获取原文并翻译 | 示例
       

摘要

Hand-foot-and-mouth disease (HFMD), caused by enterovirus, is a threat to public health worldwide. To date, enterovirus 71 (EV71) has been one of the major causative agents of HFMD in the Pacific-Asia region, and outbreaks with EV71 cause millions of infections. However, no drug is currently available for clinical therapeutics. In our previous works, we developed a set of protease inhibitors (PIs) targeting the EV71 3C protease (3C(pro)). Among these are NK-1.8k and NK-1.9k, which have various active groups and high potencies and selectivities. In the study described here, we determined the structures of the PI NK-1.8k in complex with wild-type (WT) and drug-resistant EV71 3C(pro). Comparison of these structures with the structure of unliganded EV71 3Cpro and its complex with AG7088 indicated that the mutation of N69 to a serine residue destabilized the S2 pocket. Thus, the mutation influenced the cleavage activity of EV71 3C(pro) and the inhibitory activity of NK-1.8k in an in vitro protease assay and highlighted that site 69 is an additional key site for PI design. More information for the optimization of the P1' to P4 groups of PIs was also obtained from these structures. Together with the results of our previous works, these in-depth results elucidate the inhibitory mechanism of PIs and shed light to develop PIs for the clinical treatment of infections caused by EV71 and other entero-viruses.
机译:由肠道病毒引起的手口疾病(HFMD)是全世界对公共卫生的威胁。迄今为止,肠道病毒71(eV71)是太平洋 - 亚洲地区HFMD的主要致病因子之一,eV71爆发导致数百万感染。但是,目前没有药物可用于临床治疗剂。在我们以前的作品中,我们开发了一组靶向EV71 3C蛋白酶(3C(Pro))的蛋白酶抑制剂(PIS)。其中的是NK-1.8K和NK-1.9K,具有各种活性组和高型效力和选择性。在此处描述的研究中,我们确定了与野生型(WT)和耐药EV71 3C(Pro)复合物中PI NK-1.8K的结构。这些结构与eV71 3CPRO结构的结构的比较及其与AG7088的复合物表明,N69的突变使丝氨酸残留物不稳定S2袋。因此,突变影响了EV71 3C(PRO)的切割活性和NK-1.8K在体外蛋白酶测定中的抑制活性,并强调了部位69是PI设计的额外关键部位。还从这些结构中获得了用于优化P1'至P4组P4组的更多信息。与我们以前的作品的结果一起,这些深入的结果阐明了PIS和SHED光的抑制机制,为EV71和其他肠道病毒引起的感染临床治疗的PIS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号